| # | Drug | Count |
|---|---|---|
| 0 | SOTATERCEPT-CSRK | 19 |
| 1 | TREPROSTINIL | 11 |
| 2 | TADALAFIL | 8 |
| 3 | AMBRISENTAN | 6 |
| 4 | 0XYGEN | 5 |
| 5 | MACITENTAN | 5 |
| 6 | OXYGEN | 5 |
| 7 | SILDENAFIL | 5 |
| 8 | SILDENAFIL CITRATE | 5 |
| 9 | ASPIRIN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOTATERCEPT-CSRK | 19 | 0.0031 |
| 1 | LEVALBUTEROL TARTRATE | 2 | 0.0005 |
| 2 | MIDODRINE HYDROCHLORIDE | 2 | 0.0004 |
| 3 | KETAMINE HYDROCHLORIDE | 2 | 0.0004 |
| 4 | COLESTIPOL HYDROCHLORIDE | 1 | 0.0004 |
| 5 | SCOPOLAMINE | 1 | 0.0003 |
| 6 | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | 1 | 0.0002 |
| 7 | ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0002 |
| 8 | KETOPROFEN | 2 | 0.0001 |
| 9 | SILDENAFIL POWDER, | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 1 | Prostacycline Vasodilator [EPC] | 12 | 0.0001 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 10 | 0.0001 |
| 3 | Anticholinergic [EPC] | 1 | 0.0001 |
| 4 | Endothelin Receptor Antagonist [EPC] | 11 | 0.0001 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 7 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |